Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112375015A reveals a high-yield, three-step synthesis for di-tert-butyloxycarbonylamino oxyacetic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110092735B reveals a high-yield Negishi coupling route for Eluxadoline intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical clients.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN111777520B reveals a safe, high-yield synthesis route for dimethylamino phenyl acetic acid intermediates, offering significant cost and safety advantages.
Patent CN101709047A details a robust total synthesis of Pyrrolysine using thiomethyl protection. This report analyzes cost reduction and supply chain reliability for this critical amino acid intermediate.
Novel magnesium-catalyzed asymmetric allylation for Sitagliptin intermediate. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN108948077B details a green cobalt-catalyzed synthesis of alpha-phosphorylated amino acid esters using air oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN110747489B reveals a novel electroreduction method for 2-amino-4-methoxybenzoic acid derivatives, offering high-purity intermediates for Gefitinib with reduced environmental impact.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.
Novel chiral resolution method using aspartic acid eliminates chromatography, offering high purity and scalable production for pharmaceutical intermediates.
Patent CN111087344A discloses a green synthesis for diaziridine-amino acid conjugates. This report analyzes the scalable route for high-purity pharmaceutical intermediates.
Patent CN106831474B reveals a one-step rhodium-catalyzed synthesis for anticancer intermediates, offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Novel palladium-catalyzed route for alpha-amino acid esters using alkenyl ethers. Offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Patent CN114014768A details a barium-free continuous flow synthesis for high-purity tranexamic acid, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN112920066A reveals a novel palladium-catalyzed route for alpha-amino acid esters, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel rhodium-catalyzed one-step synthesis offers high selectivity and cost reduction for pharmaceutical intermediate manufacturing supply chains ensuring reliable high-purity API precursor availability.
Patent CN103483267B reveals a high-yield one-pot synthesis for aryl imidazole salts, enabling cost reduction in pharma intermediate manufacturing and reliable supply chain scalability.